The global demand for DNA Diagnostics Market is presumed to reach the market size of nearly USD 16.93 BN by 2030 from USD 11.21 BN in 2022 with a CAGR of 5.29% under the study period 2023 - 2030.
DNA diagnostics, also known as genetic testing or DNA testing, is a set of laboratory techniques and procedures used to analyze an individual's DNA (deoxyribonucleic acid) to gain information about their genetic makeup, genetic predispositions, ancestry, and potential genetic disorders or conditions. It provides valuable insights into an individual's genetic composition, helping healthcare professionals make informed decisions about disease diagnosis, risk assessment, and treatment.
Advancements in genomic research have deepened the understanding of genetic links to diseases and conditions, spurring the demand for DNA diagnostics to assess genetic predispositions and personalize healthcare. This surge in awareness among individuals about genetic testing's potential benefits for health risk assessment, ancestry tracing, and personalized medicine has significantly boosted demand. The concept of precision medicine, which customizes healthcare interventions based on individual genetic profiles, relies heavily on DNA diagnostics. Additionally, the rising prevalence of cancer and the integration of genetic information in cancer treatment decisions have fueled the market, with genetic testing being used to identify mutations and guide therapy. Pharmacogenomics, prenatal and newborn screening, direct-to-consumer testing, regulatory support, and advancements in technology have all contributed to the market's growth. Furthermore, targeted therapies, healthcare personalization, and research investments by biotech and pharmaceutical companies are expanding the utility of DNA diagnostics. As the aging population and the trend toward personalized healthcare persist, the DNA diagnostics market is expected to continue evolving, offering a wider range of tests and applications. However, ethical and privacy concerns surrounding genetic data will remain a significant aspect of the market's development.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna diagnostics. The growth and trends of dna diagnostics industry provide a holistic approach to this study.
This section of the dna diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
By Application
This section covers the regional outlook, which accentuates current and future demand for the DNA Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Diagnostics market include GE Healthcare, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina Inc., Cepheid, Hologic Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche, QIAGEN, Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . DNA DIAGNOSTICS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Technology
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
5.1 Overview by Technology
5.2 Historical and Forecast Data
5.3 Analysis by Technology
5.4 Microarrays-based Diagnostics Historic and Forecast Sales by Regions
5.5 PCR-based Diagnostics Historic and Forecast Sales by Regions
5.6 In-situ Hybridization Diagnostics Historic and Forecast Sales by Regions
5.7 NGS DNA Diagnosis Historic and Forecast Sales by Regions
6 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Cancer Genetics Tests Historic and Forecast Sales by Regions
6.5 Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagn ...